---
title: "Simvastatin - Hyperlipidemia, Familial Combined"
sidebar: mydoc_sidebar
permalink: db00641-mesh-d006950-1.html
toc: false 
---


Path ID: `DB00641_MESH_D006950_1`
{% include image.html url="images/db00641-mesh-d006950-1.png" file="db00641-mesh-d006950-1.png" alt="db00641-mesh-d006950-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D019821">MESH:D019821 </a> | Simvastatin | Drug |
| <a href="https://identifiers.org/CHEBI:169041">CHEBI:169041 </a> | simvastatin hydroxy acid | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P04035">UniProt:P04035 </a> | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Protein |
| <a href="https://identifiers.org/GO:0006695">GO:0006695 </a> | cholesterol biosynthetic process | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:P06858">UniProt:P06858 </a> | Lipoprotein lipase | Protein |
| <a href="https://identifiers.org/GO:0019433">GO:0019433 </a> | triglyceride catabolic process | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D002784">MESH:D002784 </a> | Cholesterol | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D014280">MESH:D014280 </a> | Triglycerides | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D006950">MESH:D006950 </a> | Hyperlipidemia, Familial Combined | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Simvastatin | HAS METABOLITE | Simvastatin Hydroxy Acid |
| Simvastatin Hydroxy Acid | DECREASES ACTIVITY OF | 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase |
| Simvastatin Hydroxy Acid | INCREASES ACTIVITY OF | Lipoprotein Lipase |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase | POSITIVELY REGULATES | Cholesterol Biosynthetic Process |
| Lipoprotein Lipase | POSITIVELY REGULATES | Triglyceride Catabolic Process |
| Cholesterol Biosynthetic Process | INCREASES ABUNDANCE OF | Cholesterol |
| Triglyceride Catabolic Process | DECREASES ABUNDANCE OF | Triglycerides |
| Cholesterol | POSITIVELY CORRELATED WITH | Hyperlipidemia, Familial Combined |
| Triglycerides | POSITIVELY CORRELATED WITH | Hyperlipidemia, Familial Combined |
|---------|-----------|---------|

Comment: Simvastatin is a prodrug in which the 6-membered lactone ring of simvastatin is hydrolyzed to generate the simvastatin hydroxy acid (beta,delta-dihydroxy acid), an active metabolite in the body.

Reference: 
  - [https://go.drugbank.com/drugs/DB00641#mechanism-of-action](https://go.drugbank.com/drugs/DB00641#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Simvastatin#Pharmacology](https://en.wikipedia.org/wiki/Simvastatin#Pharmacology)
  - [https://www.uniprot.org/uniprot/P04035#function](https://www.uniprot.org/uniprot/P04035#function)
  - [https://www.uniprot.org/uniprot/P06858#function](https://www.uniprot.org/uniprot/P06858#function)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760655/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760655/)
  - [https://en.wikipedia.org/wiki/Combined_hyperlipidemia](https://en.wikipedia.org/wiki/Combined_hyperlipidemia)
